Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation

被引:0
作者
Lingfei Zhao
Chenxia Hu
Fei Han
Dajin Chen
Yanhong Ma
Fanghao Cai
Jianghua Chen
机构
[1] Zhejiang University,Kidney Disease Center, the First Affiliated Hospital, College of Medicine
[2] Zhejiang University,Key Laboratory of Kidney Disease Prevention and Control Technology
[3] Zhejiang University,Institute of Nephrology
[4] Zhejiang University,State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine
来源
Cell and Tissue Research | 2021年 / 384卷
关键词
Mesenchymal stromal cells; Machine perfusion; Organ preservation; Solid organ transplantation; Regenerative medicine;
D O I
暂无
中图分类号
学科分类号
摘要
Organ preservation is a prerequisite for an urgent increase in the availability of organs for solid organ transplantation (SOT). An increasing amount of expanded criteria donor (ECD) organs are used clinically. Currently, the paradigm of organ preservation is shifting from simple reduction of cellular metabolic activity to maximal simulation of an ex vivo physiological microenvironment. An ideal organ preservation technique should not only preserve isolated organs but also offer the possibility of rehabilitation and evaluation of organ function prior to transplantation. Based on the fact that mesenchymal stromal cells (MSCs) possess strong regeneration properties, the combination of MSCs with machine perfusion (MP) is expected to be superior to conventional preservation methods. In recent years, several studies have attempted to use this strategy for SOT showing promising outcomes. With better organ function during ex vivo preservation and the potential of utilization of organs previously deemed untransplantable, this strategy is meaningful for patients with organ failure to help overcome organ shortage in the field of SOT.
引用
收藏
页码:13 / 23
页数:10
相关论文
共 267 条
[31]  
Medica D(2015)Twelve-hour hypothermic machine perfusion for donor heart preservation leads to improved ultrastructural characteristics compared to conventional cold storage Ann Transplant 20 461-49
[32]  
Cao H(2009)Machine perfusion or cold storage in deceased-donor kidney transplantation N Engl J Med 360 7-55
[33]  
Yang L(2016)Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation J Heart Lung Transplant 35 1245-586
[34]  
Hou B(2017)Mesenchymal stem cells inhibit T cell activation by releasing TGF-β1 from TGF-β1/GARP complex Oncotarget 8 99784-149
[35]  
Sun D(2009)Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production Nat Med 15 42-752
[36]  
Lin L(2014)The effect of preservation solutions for storage of liver allografts on transplant outcomes: a systematic review and meta-analysis Ann Surg 260 46-1330
[37]  
Song HL(2008)A systematic review of kidney transplantation from expanded criteria donors Am J Kidney Dis 52 553-2134
[38]  
Shen ZY(2010)Time to think out of the (ice) box Curr Opin Organ Transplant 15 147-379
[39]  
Collino F(2008)Solving the organ shortage crisis: the 7th Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium Am J Transplant 8 745-255
[40]  
Bruno S(2020)Treating ischemically damaged porcine kidneys with human bone marrow- and adipose tissue-derived mesenchymal stromal cells during ex vivo normothermic machine perfusion Stem Cells Dev 29 1320-43